Related Experiment Video
Updated: May 12, 2025
08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
20.1K
Ultra-hypofractionation for node-positive prostate cancer: pushing boundaries and redefining standards
Jennifer Le Guévelou1, Mathilde Jeandin2, Antonio Angrisani3
1Laboratoire de traitement du signal et de l'image, Rennes University, Rennes, France.
Prostate Cancer and Prostatic Diseases
|May 9, 2025
Abstract
None:
Radiotherapy is a cornerstone in the management of node-positive prostate cancer. Advances in imaging modalities and radiation therapy techniques have led to the evolution of treatment standards for this patient population. This review aims to explore the therapeutic advancements of the past decade, with a focus on the role of ultra-hypofractionated radiotherapy in node-positive prostate cancer.
